The design-make-test-analyze (DMTA) cycle in drug discovery is time-consuming and costly. The BIOVIA Generative Therapeutics Design solution is an AI/ML-based ideation engine to help chemists decide what to make next. Read more:
The design-make-test-analyze (DMTA) cycle in drug discovery is time-consuming and costly. The BIOVIA Generative Therapeutics Design solution is an AI/ML-based ideation engine to help chemists decide what to make next. Read more:
